Patient-derived xenografts (PDX) are a model of cancer in which tissues or cells from a patient's tumor are implanted in immunodeficient or humanized mice. The PDX model is used to create an environment that allows the cancer to grow naturally, monitor and evaluate the original patient's treatment accordingly.
The global PDX Models market was valued at US$ 331.6 million in 2023 and is anticipated to reach US$ 593.9 million by 2030, witnessing a CAGR of 8.5% during the forecast period 2024-2030.
Global top 5 manufacturers of patient-derived xenograft (PDX) models occupied for a share nearly 45 percent, key players are Crown Bioscience, Champions Oncology, Wuxi Apptec, EPO Berlin-Buch, and Oncodesign, etc. Geographically speaking, Asia Pacific holds the most of global market share, about 35%. North America holds about 30% of share, while Europe followed by nearly 20%. In terms of type, mouse model accounted for nearly 75%, and rat model accounted for a share of 25%,The application of patient-derived xenograft (PDX) models includes preclinical drug development and biomarker analysis. Preclinical drug development shares over 75%, while biomarker analysis shares about 20%.
This report aims to provide a comprehensive presentation of the global market for PDX Models, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PDX Models.
Report Scope
The PDX Models market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PDX Models market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PDX Models companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River
Crown Bioscience
Champion Oncology
The Jackson Laboratory
Oncodesign
Wuxi Apptec
Horizon Discovery Group
Pharmatest Services
MI Bioresearch
Creative Animodel
Urosphere
Xentech
Hera BioLabs
EPO Berlin-Buch
Segment by Type
Mice Models
Rat Models
Segment by Application
Preclinical Drug Development and Oncology Research
Biomarker Analysis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of PDX Models companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PDX Models Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Mice Models
1.2.3 Rat Models
1.3 Market by Application
1.3.1 Global PDX Models Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Preclinical Drug Development and Oncology Research
1.3.3 Biomarker Analysis
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global PDX Models Market Perspective (2019-2030)
2.2 PDX Models Growth Trends by Region
2.2.1 Global PDX Models Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 PDX Models Historic Market Size by Region (2019-2024)
2.2.3 PDX Models Forecasted Market Size by Region (2025-2030)
2.3 PDX Models Market Dynamics
2.3.1 PDX Models Industry Trends
2.3.2 PDX Models Market Drivers
2.3.3 PDX Models Market Challenges
2.3.4 PDX Models Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PDX Models Players by Revenue
3.1.1 Global Top PDX Models Players by Revenue (2019-2024)
3.1.2 Global PDX Models Revenue Market Share by Players (2019-2024)
3.2 Global PDX Models Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by PDX Models Revenue
3.4 Global PDX Models Market Concentration Ratio
3.4.1 Global PDX Models Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PDX Models Revenue in 2023
3.5 PDX Models Key Players Head office and Area Served
3.6 Key Players PDX Models Product Solution and Service
3.7 Date of Enter into PDX Models Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PDX Models Breakdown Data by Type
4.1 Global PDX Models Historic Market Size by Type (2019-2024)
4.2 Global PDX Models Forecasted Market Size by Type (2025-2030)
5 PDX Models Breakdown Data by Application
5.1 Global PDX Models Historic Market Size by Application (2019-2024)
5.2 Global PDX Models Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America PDX Models Market Size (2019-2030)
6.2 North America PDX Models Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America PDX Models Market Size by Country (2019-2024)
6.4 North America PDX Models Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe PDX Models Market Size (2019-2030)
7.2 Europe PDX Models Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe PDX Models Market Size by Country (2019-2024)
7.4 Europe PDX Models Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PDX Models Market Size (2019-2030)
8.2 Asia-Pacific PDX Models Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific PDX Models Market Size by Region (2019-2024)
8.4 Asia-Pacific PDX Models Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America PDX Models Market Size (2019-2030)
9.2 Latin America PDX Models Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America PDX Models Market Size by Country (2019-2024)
9.4 Latin America PDX Models Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PDX Models Market Size (2019-2030)
10.2 Middle East & Africa PDX Models Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa PDX Models Market Size by Country (2019-2024)
10.4 Middle East & Africa PDX Models Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Detail
11.1.2 Charles River Business Overview
11.1.3 Charles River PDX Models Introduction
11.1.4 Charles River Revenue in PDX Models Business (2019-2024)
11.1.5 Charles River Recent Development
11.2 Crown Bioscience
11.2.1 Crown Bioscience Company Detail
11.2.2 Crown Bioscience Business Overview
11.2.3 Crown Bioscience PDX Models Introduction
11.2.4 Crown Bioscience Revenue in PDX Models Business (2019-2024)
11.2.5 Crown Bioscience Recent Development
11.3 Champion Oncology
11.3.1 Champion Oncology Company Detail
11.3.2 Champion Oncology Business Overview
11.3.3 Champion Oncology PDX Models Introduction
11.3.4 Champion Oncology Revenue in PDX Models Business (2019-2024)
11.3.5 Champion Oncology Recent Development
11.4 The Jackson Laboratory
11.4.1 The Jackson Laboratory Company Detail
11.4.2 The Jackson Laboratory Business Overview
11.4.3 The Jackson Laboratory PDX Models Introduction
11.4.4 The Jackson Laboratory Revenue in PDX Models Business (2019-2024)
11.4.5 The Jackson Laboratory Recent Development
11.5 Oncodesign
11.5.1 Oncodesign Company Detail
11.5.2 Oncodesign Business Overview
11.5.3 Oncodesign PDX Models Introduction
11.5.4 Oncodesign Revenue in PDX Models Business (2019-2024)
11.5.5 Oncodesign Recent Development
11.6 Wuxi Apptec
11.6.1 Wuxi Apptec Company Detail
11.6.2 Wuxi Apptec Business Overview
11.6.3 Wuxi Apptec PDX Models Introduction
11.6.4 Wuxi Apptec Revenue in PDX Models Business (2019-2024)
11.6.5 Wuxi Apptec Recent Development
11.7 Horizon Discovery Group
11.7.1 Horizon Discovery Group Company Detail
11.7.2 Horizon Discovery Group Business Overview
11.7.3 Horizon Discovery Group PDX Models Introduction
11.7.4 Horizon Discovery Group Revenue in PDX Models Business (2019-2024)
11.7.5 Horizon Discovery Group Recent Development
11.8 Pharmatest Services
11.8.1 Pharmatest Services Company Detail
11.8.2 Pharmatest Services Business Overview
11.8.3 Pharmatest Services PDX Models Introduction
11.8.4 Pharmatest Services Revenue in PDX Models Business (2019-2024)
11.8.5 Pharmatest Services Recent Development
11.9 MI Bioresearch
11.9.1 MI Bioresearch Company Detail
11.9.2 MI Bioresearch Business Overview
11.9.3 MI Bioresearch PDX Models Introduction
11.9.4 MI Bioresearch Revenue in PDX Models Business (2019-2024)
11.9.5 MI Bioresearch Recent Development
11.10 Creative Animodel
11.10.1 Creative Animodel Company Detail
11.10.2 Creative Animodel Business Overview
11.10.3 Creative Animodel PDX Models Introduction
11.10.4 Creative Animodel Revenue in PDX Models Business (2019-2024)
11.10.5 Creative Animodel Recent Development
11.11 Urosphere
11.11.1 Urosphere Company Detail
11.11.2 Urosphere Business Overview
11.11.3 Urosphere PDX Models Introduction
11.11.4 Urosphere Revenue in PDX Models Business (2019-2024)
11.11.5 Urosphere Recent Development
11.12 Xentech
11.12.1 Xentech Company Detail
11.12.2 Xentech Business Overview
11.12.3 Xentech PDX Models Introduction
11.12.4 Xentech Revenue in PDX Models Business (2019-2024)
11.12.5 Xentech Recent Development
11.13 Hera BioLabs
11.13.1 Hera BioLabs Company Detail
11.13.2 Hera BioLabs Business Overview
11.13.3 Hera BioLabs PDX Models Introduction
11.13.4 Hera BioLabs Revenue in PDX Models Business (2019-2024)
11.13.5 Hera BioLabs Recent Development
11.14 EPO Berlin-Buch
11.14.1 EPO Berlin-Buch Company Detail
11.14.2 EPO Berlin-Buch Business Overview
11.14.3 EPO Berlin-Buch PDX Models Introduction
11.14.4 EPO Berlin-Buch Revenue in PDX Models Business (2019-2024)
11.14.5 EPO Berlin-Buch Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Charles River
Crown Bioscience
Champion Oncology
The Jackson Laboratory
Oncodesign
Wuxi Apptec
Horizon Discovery Group
Pharmatest Services
MI Bioresearch
Creative Animodel
Urosphere
Xentech
Hera BioLabs
EPO Berlin-Buch
听
听
*If Applicable.
